Nancy S Gavert (N Gavert, Nancy Gavert)

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Top Venues

Science (New York, N.Y.)

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Chani Stossel, Maria Raitses-Gurevich, Dikla Atias, Tamar Beller, Yulia Glick Gorman, Sharon Halperin, Eyal Peer, Robert E Denroche, Amy Zhang, Faiyaz Notta, Julie M Wilson, Grainne M O'Kane, Elina Haimov Talmoud, Nora Amison, Michael Schvimer, Seth J Salpeter, Vered Bar, Adi Zundelevich, Michael Mints, Rotem Tal, Gal Dinstag, Yaron Kinar, Yonatan Eliezer, Uri Ben-David, Nancy S Gavert, Ravid Straussman, Steven J Gallinger, Raanan Berger, Talia Golan
Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA-Associated Pancreatic Cancer in the Clinical and Preclinical Setting. Cancer discovery (2023)
Arka Saha, Nancy S Gavert, Thomas Brabletz, Avri Ben-Ze'ev
An Increase in Mucin2 Expression Is Required for Colon Cancer Progression Mediated by L1. International journal of molecular sciences 24 (17) (2023)
Nancy S Gavert, Yaara Zwang, Roi Weiser, Orli Greenberg, Sharon Halperin, Oded Jacobi, Giuseppe Mallel, Oded Sandler, Adi Jacob Berger, Erez Stossel, Daniil Rotin, Albert Grinshpun, Iris Kamer, Jair Bar, Guy Pines, Daniel Saidian, Ilan Bar, Shay Golan, Eli Rosenbaum, Andrei Nadu, Eytan Ben-Ami, Rony Weitzen, Hovav Nechushtan, Talia Golan, Baruch Brenner, Aviram Nissan, Ofer Margalit, Dov Hershkovitz, Guy Lahat, Ravid Straussman
Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer. Nature cancer 3 (2) (2022)
Adi Jacob Berger, Elinor Gigi, Lana Kupershmidt, Zohar Meir, Nancy S Gavert, Yaara Zwang, Amir Prior, Shlomit Gilad, Uzi Harush, Izhak Haviv, Salomon M Stemmer, Galia Blum, Emmanuelle Merquiol, Mariya Mardamshina, Sivan Kaminski Strauss, Gilgi Friedlander, Jair Bar, Iris Kamer, Yitzhak Reizel, Tamar Geiger, Yitzhak Pilpel, Yishai Levin, Amos Tanay, Baruch Barzel, Hadas Reuveni, Ravid Straussman
IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy. Nature cancer 2 (10) (2021)
Deborah Nejman, Ilana Livyatan, Garold Fuks, Nancy S Gavert, Yaara Zwang, Leore T Geller, Aviva Rotter-Maskowitz, Roi Weiser, Giuseppe Mallel, Elinor Gigi, Arnon Meltser, Gavin M Douglas, Iris Kamer, Vancheswaran Gopalakrishnan, Tali Dadosh, Smadar Levin-Zaidman, Sofia Avnet, Tehila Atlan, Zachary A Cooper, Reetakshi Arora, Alexandria P Cogdill, Md Abdul Wadud Khan, Gabriel Ologun, Yuval Bussi, Adina Weinberger, Maya Lotan-Pompan, Ofra Golani, Gili Perry, Merav Rokah, Keren Bahar-Shany, Elisa A Rozeman, Christian U Blank, Anat Ronai, Ron Shaoul, Amnon Amit, Tatiana Dorfman, Ran Kremer, Zvi R Cohen, Sagi Harnof, Tali Siegal, Einav Yehuda-Shnaidman, Einav Nili Gal-Yam, Hagit Shapira, Nicola Baldini, Morgan G I Langille, Alon Ben-Nun, Bella Kaufman, Aviram Nissan, Talia Golan, Maya Dadiani, Keren Levanon, Jair Bar, Shlomit Yust-Katz, Iris Barshack, Daniel S Peeper, Dan J Raz, Eran Segal, Jennifer A Wargo, Judith Sandbank, Noam Shental, Ravid Straussman
The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science (New York, N.Y.) 368 (6494) (2020)
Rotem Ben-Hamo, Adi Jacob Berger, Nancy S Gavert, Mendy Miller, Guy Pines, Roni Oren, Eli Pikarsky, Cyril H Benes, Tzahi Neuman, Yaara Zwang, Sol Efroni, Gad A Getz, Ravid Straussman
Predicting and affecting response to cancer therapy based on pathway-level biomarkers. Nature communications 11 (1) (2020)
Leore T Geller, Michal Barzily-Rokni, Tal Danino, Oliver H Jonas, Noam Shental, Deborah Nejman, Nancy S Gavert, Yaara Zwang, Zachary A Cooper, Kevin Shee, Christoph A Thaiss, Alexandre Reuben, Jonathan Livny, Roi Avraham, Dennie T Frederick, Matteo Ligorio, Kelly Chatman, Stephen E Johnston, Carrie M Mosher, Alexander Brandis, Garold Fuks, Candice R Gurbatri, Vancheswaran Gopalakrishnan, Michael P Kim, Mark W Hurd, Matthew Katz, Jason B Fleming, Anirban Maitra, David A Smith, Matt Skalak, Jeffrey Bu, Monia Michaud, Sunia A Trauger, Iris Barshack, Talia Golan, Judith Sandbank, Keith T Flaherty, Anna Mandinova, Wendy S Garrett, Sarah P Thayer, Cristina R Ferrone, Curtis Huttenhower, Sangeeta N Bhatia, Dirk Gevers, Jennifer A Wargo, Todd R Golub, Ravid Straussman
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science (New York, N.Y.) 357 (6356) (2018)
A Shvab, G Haase, A Ben-Shmuel, Nancy S Gavert, T Brabletz, S Dedhar, A Ben-Ze'ev
Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression. Oncogene 35 (5) (2015)